サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/24 | 1,181 | 1,220 | 1,156 | 1,174 | -3 | -0.3% | 197,300 |
| 2017/04/21 | 1,270 | 1,270 | 1,176 | 1,177 | +14 | +1.2% | 714,900 |
| 2017/04/20 | 1,097 | 1,163 | 1,084 | 1,163 | +87 | +8.1% | 296,200 |
| 2017/04/19 | 1,041 | 1,080 | 1,035 | 1,076 | +30 | +2.9% | 155,100 |
| 2017/04/18 | 1,072 | 1,076 | 1,040 | 1,046 | -26 | -2.4% | 212,100 |
| 2017/04/17 | 1,070 | 1,106 | 1,063 | 1,072 | -13 | -1.2% | 138,600 |
| 2017/04/14 | 1,150 | 1,152 | 1,084 | 1,085 | -67 | -5.8% | 217,600 |
| 2017/04/13 | 1,169 | 1,186 | 1,148 | 1,152 | -3 | -0.3% | 150,200 |
| 2017/04/12 | 1,161 | 1,180 | 1,140 | 1,155 | -18 | -1.5% | 161,800 |
| 2017/04/11 | 1,120 | 1,179 | 1,110 | 1,173 | +59 | +5.3% | 207,400 |
| 2017/04/10 | 1,103 | 1,142 | 1,103 | 1,114 | +4 | +0.4% | 89,900 |
| 2017/04/07 | 1,067 | 1,116 | 1,048 | 1,110 | +43 | +4% | 208,200 |
| 2017/04/06 | 1,100 | 1,107 | 1,052 | 1,067 | -46 | -4.1% | 166,700 |
| 2017/04/05 | 1,120 | 1,140 | 1,100 | 1,113 | +5 | +0.5% | 55,400 |
| 2017/04/04 | 1,168 | 1,185 | 1,099 | 1,108 | -61 | -5.2% | 162,300 |
| 2017/04/03 | 1,185 | 1,186 | 1,156 | 1,169 | -9 | -0.8% | 127,200 |
| 2017/03/31 | 1,156 | 1,188 | 1,156 | 1,178 | +22 | +1.9% | 121,400 |
| 2017/03/30 | 1,181 | 1,199 | 1,156 | 1,156 | -30 | -2.5% | 197,300 |
| 2017/03/29 | 1,160 | 1,192 | 1,153 | 1,186 | +16 | +1.4% | 252,100 |
| 2017/03/28 | 1,084 | 1,192 | 1,080 | 1,170 | +93 | +8.6% | 496,200 |
| 2017/03/27 | 1,080 | 1,122 | 1,075 | 1,077 | +10 | +0.9% | 244,400 |
| 2017/03/24 | 1,073 | 1,081 | 1,060 | 1,067 | -10 | -0.9% | 103,000 |
| 2017/03/23 | 1,030 | 1,080 | 1,021 | 1,077 | +57 | +5.6% | 150,100 |
| 2017/03/22 | 1,035 | 1,048 | 1,019 | 1,020 | -39 | -3.7% | 127,200 |
| 2017/03/21 | 1,036 | 1,065 | 1,012 | 1,059 | -3 | -0.3% | 244,000 |
| 2017/03/17 | 1,083 | 1,084 | 1,056 | 1,062 | -25 | -2.3% | 172,900 |
| 2017/03/16 | 1,062 | 1,090 | 1,060 | 1,087 | +23 | +2.2% | 138,100 |
| 2017/03/15 | 1,083 | 1,090 | 1,064 | 1,064 | -18 | -1.7% | 152,000 |
| 2017/03/14 | 1,102 | 1,105 | 1,072 | 1,082 | -29 | -2.6% | 316,300 |
| 2017/03/13 | 1,128 | 1,130 | 1,111 | 1,111 | -20 | -1.8% | 116,900 |
| 2017/03/10 | 1,150 | 1,150 | 1,121 | 1,131 | +9 | +0.8% | 142,600 |
| 2017/03/09 | 1,133 | 1,148 | 1,122 | 1,122 | -11 | -1% | 149,500 |
| 2017/03/08 | 1,176 | 1,176 | 1,121 | 1,133 | -53 | -4.5% | 495,100 |
| 2017/03/07 | 1,209 | 1,212 | 1,161 | 1,186 | -23 | -1.9% | 353,500 |
| 2017/03/06 | 1,210 | 1,219 | 1,208 | 1,209 | +1 | +0.1% | 91,400 |
| 2017/03/03 | 1,218 | 1,223 | 1,208 | 1,208 | -10 | -0.8% | 150,900 |
| 2017/03/02 | 1,230 | 1,233 | 1,218 | 1,218 | -1 | -0.1% | 83,400 |
| 2017/03/01 | 1,221 | 1,231 | 1,214 | 1,219 | -2 | -0.2% | 125,200 |
| 2017/02/28 | 1,235 | 1,242 | 1,220 | 1,221 | -14 | -1.1% | 142,200 |
| 2017/02/27 | 1,219 | 1,255 | 1,213 | 1,235 | +10 | +0.8% | 282,800 |
| 2017/02/24 | 1,224 | 1,234 | 1,219 | 1,225 | +2 | +0.2% | 112,900 |
| 2017/02/23 | 1,226 | 1,231 | 1,219 | 1,223 | -3 | -0.2% | 117,400 |
| 2017/02/22 | 1,240 | 1,243 | 1,225 | 1,226 | -11 | -0.9% | 71,000 |
| 2017/02/21 | 1,233 | 1,245 | 1,229 | 1,237 | ±0 | ±0% | 53,600 |
| 2017/02/20 | 1,250 | 1,256 | 1,235 | 1,237 | -15 | -1.2% | 77,100 |
| 2017/02/17 | 1,242 | 1,261 | 1,242 | 1,252 | -2 | -0.2% | 42,900 |
| 2017/02/16 | 1,295 | 1,299 | 1,251 | 1,254 | -38 | -2.9% | 138,400 |
| 2017/02/15 | 1,259 | 1,305 | 1,253 | 1,292 | +39 | +3.1% | 373,500 |
| 2017/02/14 | 1,230 | 1,255 | 1,223 | 1,253 | +23 | +1.9% | 160,800 |
| 2017/02/13 | 1,222 | 1,233 | 1,217 | 1,230 | +6 | +0.5% | 96,700 |
2001～
2050
件表示中 / 2501件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 219,100円 | - | - | 0.00% | - | 101.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 377,900円 | -6.4% | -71.8% | 5.03% | 42.21倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 310,000円 | +21.7% | +999.9% | 0.00% | 12.99倍 | 4.30倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,100円 | +7.9% | -3.3% | 2.73% | 8.15倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,800円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
